Del(5q) Deletion FISH Probe Kit: In-Vitro Diagnostic to detect deletions in chromosome location f...
FDA Device Recall #Z-0741-2022 — Class II — January 18, 2022
Recall Summary
| Recall Number | Z-0741-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 18, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Cytocell Ltd. |
| Location | Cambridge, N/A |
| Product Type | Devices |
| Quantity | 19 kits |
Product Description
Del(5q) Deletion FISH Probe Kit: In-Vitro Diagnostic to detect deletions in chromosome location from patients with AML or MDS Catalog Number: USA-LPH024
Reason for Recall
individual components have been labelled with incorrect colours. The red and green colours are opposite to those specified in the product labelling. The EGR1 probe is labelled in green rather than red and the control probe labelled in red rather than green. The expected positive signal pattern in the case of 1x deleted 5q will be 1G2R instead of 1R2G, an incorrect result
Distribution Pattern
US Nationwide distribution in the states of Hawaii, Missouri, Pennsylvania, Tennessee.
Lot / Code Information
Lot Number: 075711 Exp. Date: 2023-06-22 UDI: (01)05055844901551(17)230622(10)075 711
Other Recalls from Cytocell Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2210-2023 | Class II | RET Distal Probe. Used in Fluorescence in situ ... | May 24, 2023 |
| Z-2209-2023 | Class II | RET Proximal Probe. Used in Fluorescence in sit... | May 24, 2023 |
| Z-0353-2023 | Class II | CytoCell BCL11B Proximal in FITC Spectrum-LDT f... | Oct 27, 2022 |
| Z-0341-2023 | Class II | CytoCell BCL11B Distal in Texas Red Spectrum- A... | Oct 27, 2022 |
| Z-0824-2022 | Class III | Cytocell 8 Square Template Slides (Glass)- micr... | Feb 14, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.